Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Sulphonylurea Hypoglycaemic Drugs

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aggarwal, V. and Sunshine, I.: Determination of sulfonylureas and metabolites by pyrolysis gas chromatography. Clinical Chemistry 20: 200–204(1974).

    PubMed  CAS  Google Scholar 

  • Alexander, R.W.: Prolonged hypoglycemia following acetohexamide administration. Report of two cases with impaired renal function. Diabetes 15: 362–364 (1966).

    CAS  Google Scholar 

  • Ambrogi, V.; Artini, D.; Fucella, L.M.; Goldaniga, G.; Orsini, G.; Ronchi, R.; Tamassia, V.; Valzelli, G. and Angelucci, R.: Farmacocinetica e metabolismo in animali da esperimento e nell uomo della N-4-[β-(5 metilpirazina-2-carbossiamido)-etil]-benzensolfonil -N′-cicloesil-urea (K 4024). Bolletino Chimico Farmaceutico 111: 251–264 (1972).

    CAS  Google Scholar 

  • Anderson, J.; Coulson, R.; Grassick, B.D.M.; Morris, B.A.; Thomas, W.D.; Tomlinson, R.W.S. and Woodroffe, R.: Plasma insulin and metabolic study on diabetes treated with glibenclamide. Postgraduate Medical Journal (Suppl. Dec): 36–41 (1970).

    Google Scholar 

  • Andreasen, P.B. and Vesell. E.S.: Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. Clinical Pharmacology and Therapeutics 16: 1059–1065 (1974).

    PubMed  CAS  Google Scholar 

  • Ashcroft, S.J.H.: Glucoreceptor mechanisms and the control of insulin release and biosynthesis. Diabetologia 18: 5–15 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Balant, L.: Les sulfonylurees hypoglycemiantes: Un Probléme de générations? Considérations pharmacocinétiques et pharmacodynamiques. Diabète et Métabolisme 4: 135–143 (1978).

    PubMed  CAS  Google Scholar 

  • Balant, L. and Fabre, J.: Influence of renal insufficiency on the behaviour of hypoglycemic sulfonylureas; in Keen et al. (Eds) Gliclazide and the Treatment of Diabetes, pp.83–89 (Royal Society of Medicine Congress Series 20, 1980).

  • Balant, L.; Zahnd, G.R.; Gorgia, A.; Schwarz, R. and Fabre, J.: Pharmacokinetics of glipizide in man: Influence of renal insufficiency. Diabetologia 9 (Suppl.): 331–388 (1973).

    Article  CAS  Google Scholar 

  • Balant, L.; Fabre, J. and Zahnd, G.R.: Comparison of the pharmacokinetics of glipizide and glibenclamide in man. European Journal of Clinical Pharmacology 8: 63–69 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Balant, L.; Zahnd, G.R.; Weber, F. and Fabre, J.: Behaviour of glibenclamide on repeated administration to diabetic patients. European Journal of Clinical Pharmacology 11: 19–25 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Balant, L.; Fabre, J.; Loutan, L. and Samimi, H.: Does 4-trans-hydroxy-glibenclamide show hypoglycemic activity?. Arzneimittel-Forschung 29: 162–163 (1979).

    PubMed  CAS  Google Scholar 

  • Becker, R.: Fluorimetrische Bestimmung von Glibornurid in Plasma und Serum mit 7-Chlor-4-nitrobenzo-2-oxa-1,3-diazol. Arzneimittel-Forschung 27: 102–105 (1977).

    PubMed  CAS  Google Scholar 

  • Berger, W.: 88 Schwere Hypoglykämiezwischenfälle unter der Behandlung mit Sulfonylharnstoffen. Schweizerische Medizinische Wochenschrift 71: 1013–1022 (1971).

    Google Scholar 

  • Bigler, F.; Quitt, P.; Vecchi, M. and Vetter, W.: Ueber den Stoffwechsel von Glibornurid beim Menschen. Arzneimittel-Forschung 22: 2191–2198 (1972).

    PubMed  CAS  Google Scholar 

  • Birk, W.; Schmidt, H.A.E. and Petrides, P.: 14C-Gliben-clamidkonzentration im Serum und 14C-Glibenclamid-ausscheidung im Urin bei gleichzeitiger Bestimmung von Blutzucker und Insulin beim Diabetiker. Arzneimittel-Forschung 28: 330–337 (1978).

    PubMed  CAS  Google Scholar 

  • Bladh, E. and Norden, Å: A method for determining 1-butyl-3-p-tolyl-sulfonylurea (tolbutamide) in human blood serum. Acta Pharmacologica et Toxicologica 14: 188–194 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Block, M.B. and Rubenstein, A.H.: Spontaneous hypoglycemia in diabetic patients with renal insufficiency. Journal of the American Medical Association 213: 1863–1866 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Braselton, W.E., Jr; Ashline, H.C. and Bransome, E.D., Jr.: Formation of thermally stable derivates for determination of tolbutamide and chlorpropamide by gas chromatography. Analytical Letters 8: 301–313 (1975).

    Article  CAS  Google Scholar 

  • Braselton, W.E.; Bransome, E.D.; Ashline, H.C.; Stewart, J.T. and Honigberg, I.L.: Gas chromatographic and mass spectral properties of sulfonylurea N-methyl-N′-perfluoroacyl derivatives. Analytical Chemistry 48: 1386–1394 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Braselton, W.E.; Bransome, E.D. and Huff, T.A.: Measurement of antidiabetic sulfonylurea in serum by gas chromatography with electron-capture detection. Diabetes 26: 50–57 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Breidahl, H.D.: What patients with diabetes want to know about their therapy. Drugs 19: 135–140 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Bressler, R.: Control of the blood glucose in diabetes mellitus: Is it valuable?. Is it feasible? Drugs 17: 461–470 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Pakes, G.E.; Speight, T.M. and Avery, G.S.: Glipizide: A review of its pharmacological properties and therapeutic use. Drugs 18: 329–353 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Brook, R.; Schrogie, J.J. and Solomon, H.M.: Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man. Clinical Pharmacology and Therapeutics 9: 314–317 (1968).

    PubMed  CAS  Google Scholar 

  • Brotherton, P.M.; Grieveson, P. and McMartin, C.: A study of the metabolic fate of chlorpropamide in man. Clinical Pharmacology and Therapeutics 10: 505–514 (1969).

    PubMed  CAS  Google Scholar 

  • Campbell, D.B.; Adriaenssens, P.; Hopkins, Y.W.; Gordon, B. and Williams, J.R.B.: Pharmacokinetics and metabolism of gliclazide: A review; in Keen et al. (Eds) Gliclazide and the Treatment of Diabetes, pp.71–82 (Royal Society of Medicine Congress Series 20, 1980).

  • Carmichael, R.H.: A method for the routine determination of chlorpropamide in plasma. Clinical Chemistry 5: 597–602 (1959).

    PubMed  CAS  Google Scholar 

  • Castoldi, D. and Tofanetti, O.: Gas chromatographic determination of glibenclamide in plasma. Clinica Chimica Acta 93: 195–198 (1979).

    Article  CAS  Google Scholar 

  • Cerasi, E.; Efendic, S.; Thornqvist, C. and Luft, R.: Effect of two sulfonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. Acta Endocrinologica 91: 282–293 (1979).

    PubMed  CAS  Google Scholar 

  • Christensen, L.K. and Skorsted, L.: Inhibition of drug metabolism by chloramphenicol. Lancet 2: 1397–1399 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Christensen, L.K.; Hansen, J.M. and Kristensen, M.: Sulphaphenazone-induced hypoglycaemic attacks in tolbutamide-treated diabetics. Lancet 2: 1298–1301 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Chulski, Th.: Spectrophotometric determination of tolbutamide in plasma. Journal of Laboratory and Clinical Medicine 53: 490–494 (1959).

    PubMed  CAS  Google Scholar 

  • Cohen, B.D.; Galloway, J.A.; McMahon, R.E.; Culp, H.W.; Root, M.A. and Henriques, K.J.: Carbohydrate metabolism in uremia: Blood glucose response to sulfonylurea. American Journal of the Medical Sciences 254: 608–618 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Craig, J.W.; Miller, M.; Mills, F.D. and Nickerson, N.: A comparison of the acute hypoglycemic potencies of tolbutamide and chlorpropamide. Annals of the New York Academy of Sciences 74: 618–620 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Crooks, M.J. and Brown, K.F.: Binding of sulfonylureas to serum albumin. Journal of Pharmaceutical Sciences 62: 1904–1906 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Crooks, M.J. and Brown, K.F.: The binding of sulfonylureas to serum albumin. Journal of Pharmacy and Pharmacology 26: 304–311 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Crooks, M.J. and Brown, K.F.: Interaction of glipizide with human serum albumin. Biochemical Pharmacology 24: 298–299 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Desnoyers, P.; Labaume, J.; Anstett, M.; Herrera, M.; Pesquet, J. and Sabastien, J.: The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. Part 3: antistickiness activity, fibrinolytic properties and haemostatic parameters study. Arzneimittel-Forschung 22: 1691–1695 (1972).

    PubMed  CAS  Google Scholar 

  • Dubach, U.C.; Bückert, A. and Raaflaub, J.: Einfluss von Sulfonamiden auf die blutzuckersenkende Wirkung oraler Antidiabetica. Schweizerische Medizinische Wochenschrift 96: 1483–1486 (1966).

    CAS  Google Scholar 

  • Eckhardt, W.; Rudolph, R.; Sauer, H.; Schubert, W.R. and Undeutsch, D.: Zur pharmacologischen Interferenz von Glibornurid mit Sulfaphenazol, Phenylbutazon und Phenprocoumon beim Menschen. Arzneimittel-Forschung 22: 2212–2219 (1972).

    PubMed  CAS  Google Scholar 

  • Evans, M.; Glass, R.C.; Mitchard, M.; Munday, B.M. and Yates, R.: Bioavailability of chlorpropamide. British Journal of Clinical Pharmacology 7: 101–105 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Fabre, J.; Balant, L. and Zahnd, G.: Pharmacocinetique des nouvelles sulfonylurées dans les conditions normales et pathologiques; in Glasson and Benakis (Eds) Cyclic AMP, New Antidiabetic Drugs, pp.81–100 (Parasitosis Chemotherapy, Mèdecine et Hygiène, Geneva 1974).

    Google Scholar 

  • Fabre, J.; Balant, L.; Rudhardt, M. and Blanchard, P.: Perturbations pharmacocinétiques dans l’insuffisance rénale. Anomalies des métabolites et de la diffusion dans les tissus. Nouvelle Presse Médicale 8: 2677–2682 (1979).

    PubMed  CAS  Google Scholar 

  • Feinglos, M.N. and Lebovitz, H.E.: Sulphonylureas increase the number of insulin receptors. Nature 276: 184–185 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Forist, A.A. and Judy, R.W.: l-(Hexahydroazepin-l-yl)-3-p-carboxy-phenylsulfonylurea —a metabolite of tolazamide in man. Journal of Pharmacy and Pharmacology 26: 565 (1974).

    Article  CAS  Google Scholar 

  • Forist, A.A.; Miller, W.L.; Krake, J. and Struck, W.A.: Determination of plasma levels of tolbutamide (l-butyl-3-p-tolylsulfonyl-urea, Orinase). Proceedings of the Society for Experimental Biology and Medicine 96: 180–183 (1957).

    PubMed  CAS  Google Scholar 

  • Fucella, L.M.; Tamassia, V. and Valzelli, G.: Metabolism and kinetics of the hypoglycemic agent glipizide in man — comparison with glibenclamide. Journal of Clinical Pharmacology 13: 68–75 (1973).

    Google Scholar 

  • Galloway, J.A.; McMahon, R.E.; Culp, H.W.; Marshall, F.J. and Young, E.C.: Metabolism, blood levels and rate of excretion of acetohexamide in human subjects. Diabetes 16: 118–127 (1967).

    PubMed  CAS  Google Scholar 

  • Garcia, M.; Miller, M. and Moses, A.M.: Chlorpropamide-induced water retention in patients with diabetes mellitus. Annals of Internal Medicine 75: 549–554 (1971).

    Google Scholar 

  • Glogner, P.; Lange, H. and Pfab, R.: Tolbutamidstoffwechsel bei Niereninsuffizienz. Medizinische Welt 52: 2876–2878 (1968).

    PubMed  CAS  Google Scholar 

  • Glogner, P.; Heni, N. and Nissen, L.: The radioimmunological determination of glibenclamide and its metabolites in serum. Arzneimittel-Forschung 27: 1703–1706 (1977).

    PubMed  CAS  Google Scholar 

  • Gonzalez, A.R.; Khurana, R.C.; Jung, Y.; Livstone, E.; Wolinski, A.; Sinclair, C. and Danowski, T.S.: Enhanced response to tolbutamide in uremia. Acta Diabetologica Latina 9: 373–386 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Hajdu, P.; Kohler, K.F.; Schmidt, F.H. and Spingler, H.: Physikalisch-chemische und analytische Untersuchungen an HB 419. Arzneimittel-Forschung 19: 1381–1386 (1969).

    PubMed  CAS  Google Scholar 

  • Hansen, J.M. and Christensen, L.K.: Drug interactions with oral sulfonylurea hypoglycaemic drugs. Drugs 13: 24–34 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Hansten, P.D.: Drug Interactions, p.14 (Lea and Febiger, Philadelphia 1979).

    Google Scholar 

  • Hansten, P.D.: Drug Interactions, p.552 4th ed. (Lea and Febiger, Philadelphia 1979).

    Google Scholar 

  • Haupt, E.; Köberich, W.; Beyer, J. and Schöffling, K.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia 7: 449–454 (1971a).

    Article  PubMed  CAS  Google Scholar 

  • Haupt, E.; Köberich, W.; Beyer, J. and Schöffling, K.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. II. Repeated administration in combination with glucose. Diabetologia 7: 455–460 (1971b).

    Article  PubMed  CAS  Google Scholar 

  • Hedeskov, C.J.: Mechanism of glucose-induced insulin secretion. Physiological Review 60: 442–497 (1980).

    CAS  Google Scholar 

  • Held, H.; Eisert, E. and Oldershausen, H.F.: Pharmacokinetik von Glymidine (Glycodiazin) und Tolbutamid bei akuten und Chronischen Leberschäden. Arzneimittel-Forschung 23: 1801–1807 (1973).

    PubMed  CAS  Google Scholar 

  • Hellman, B.; Sehlin, J. and Täljedal, I.-B.: The pancreatic β-cell recognition of insulin secretagogues IV. Islet uptake of sulfonylureas. Diabetologia 9: 210–216 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Henquin, J.-C.: Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18: 151–160 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Hill, H.M. and Chamberlain, J.: Determination of oral antidiabetic agents in human body fluids using high-performance liquid chromatography. Journal of Chromatography 149: 349–358 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Hill, R.E. and Crechiolo, J.: Determination of serum tolbutamide and chlorpropamide by high-performance liquid chromatography. Journal of Chromatography 145: 165–168 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Hsu, P.-L.; Ma, J.K.H. and Luzzi, L.A.: Interactions of sulfonylureas with plasma proteins. Journal of Pharmaceutical Sciences 63: 570–573 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Janbon, M.; Chaptal, J.; Vedel, A. and Schaap, J.: Accidents hypoglycémiques graves par un sulfamido-thiadiazol (le VK 57 ou 2254 RP). Montpellier Médical 441: 21–22 (1942).

    Google Scholar 

  • Johnson, P.C.; Hennes, A.R.; Driscoll, T. and West, K.M.: Metabolic fate of chlorpropramide in man. Annals of the New York Academy of Sciences 74: 459–470 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Judis, J.: Binding of sulfonylureas to serum proteins. Journal of Pharmaceutical Sciences 61: 89–93 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Judis, J.: Binding of sulfonylureas to serum albumin: A response. Journal of Pharmaceutical Sciences 62: 1906–1907 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Kawashima, K.; Kuzuya, T. and Matsuda, A.: Radioimmunoassay of glibenclamide. Diabetes 28: 221–226 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Klaff, L.J.; Vinik, A.I.; Jackson, W.P.U.; Malan, E.; Kernoff, L. and Jacobs, P.: Effects of the sulfonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function. South African Medical Journal 56: 247–250 (1979).

    PubMed  CAS  Google Scholar 

  • Knauff, R.E.; Fajans, S.S.; Ramirez, E. and Conn, J.W.: Metabolic studies of chlorpropamide in normal men and in diabetic subjects. Annals of the New York Academy of Sciences 74: 603–617 (1959a).

    Article  PubMed  CAS  Google Scholar 

  • Knauff, R.E.; Fajans, S.S.; Ramirez, E. and Conn, J.W.: Metabolic half-life times, blood levels, potencies and activity patterns of metahexamide and other sulfonylurea compounds. Metabolism 8: 606–613 (1959b).

    PubMed  CAS  Google Scholar 

  • Koss, F.W.; Kopitar, Z. and Hammer, R.: The pharmacokinetic profile of Glurenorm. Diabetologia Croatica 5: 355–371 (1976).

    CAS  Google Scholar 

  • Kristensen, M. and Christensen, L.K.: Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents. Acta Diabetologica Latina 6(Suppl. 1): 115–136 (1969).

    Google Scholar 

  • Lai, C.M. and Levy, G.: Comparative pharmacokinetics of coumarin anticoagulants. XXXVII: Simultaneous in vivo displacement of dicoumarol from serum protein and tissue binding sites by tolbutamide in rats. Journal of Pharmaceutical Sciences 67: 1492–1493(1978).

    Article  PubMed  CAS  Google Scholar 

  • Larner, J.: Insulin and oral hypoglycemic drugs; glucagon; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, sixth ed., pp. 1497–1523 (Macmillan, New York 1980).

    Google Scholar 

  • Lauvaux, J.P.; Thys, O. and Sternon, J.: Les comas hypoglycémiques par sulfamides antidiabétiques. A propos de 16 cas. Acta Clinica Belgica 23: 153–162 (1968).

    PubMed  CAS  Google Scholar 

  • Lebovitz, H.E.; Feinglos, M.N.; Bucholtz, H.K. and Lebovitz, F.L.: Potentiation of insulin action: A probable mechanism for the antidiabetic action of sulfonylurea drugs. Clinical Endocrinology and Metabolism 45: 601–604 (1977).

    Article  CAS  Google Scholar 

  • Logie, A.W.; Galloway, D.B. and Petrie, J.C.: Drug interactions and long-term antidiabetic therapy. British Journal of Clinical Pharmacology 3: 1027–1032 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Loubatières, A.: Analyse du mècanisme de l’action hypoglycémiante du p-amino-benzène-sulfamido-isopropylthiodiazol (2254 RP). Comptes Rendus de la Société de Biologie (Paris) 138: 796 (1944).

    Google Scholar 

  • Loubatières, A. and Renold, A.E.; eds: Pharmacokinetics and Mode of Action of Oral Hypoglycemic Agents, p.735 (Acta Diabetologica Latina, Milano 1969).

    Google Scholar 

  • Loubatières, A.; Mariani, M.-M.; Ribes, G. and Alric, R.: Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Acta Diabetologica Latina 10: 261–282 (1973).

    Article  Google Scholar 

  • Lumholtz, B.; Siersbaek-Nielsen, K.; Skorsted, L.; Kampmann, J. and Hansen, J.M.: Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism. Clinical Pharmacology and Therapeutics 17: 731–734 (1975).

    PubMed  CAS  Google Scholar 

  • Malaisse, W.J.: Insulin secretion: Multifactorial regulation for a single process of release. Diabetologia 9: 167–173 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Marble, A.; Selenkow, H.A.; Rose, L.I.; Dluhy, R.G. and Williams, G.H.: Endocrine Diseases; in Avery (Ed) Drug Treatment, pp.493–553, 2nd ed. (ADIS, Sydney 1980).

    Google Scholar 

  • Martin, E.W.: Drug Interaction Index 1978/79, p.312 (Lippincott, Philadelphia 1978).

    Google Scholar 

  • Martindale — The Extra Pharmacopeia, 27th ed. (A. Wade, Ed.), pp.808–823 (Pharmaceutical Press, London 1977).

    Google Scholar 

  • Matin, S.B. and Knight, J.B.: The use of solid probe chemical ionization mass spectrometry and gas chromatography-chemical ionization mass spectrometry in quantitation of drugs in biological fluids. Determination of tolbutamide and its metabolites in human plasma. Biomedical Mass Spectrometry 1: 323–328 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Matin, S.B. and Rowland, M.: Determination of tolbutamide and chlorpropamide in biological fluids. Journal of Pharmacy and Pharmacology 25: 186–188 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Matin, S.B.; Wan, S.H. and Karam, J.H.: Pharmacokinetics of tolbutamide: Prediction by concentration in saliva. Clinical Pharmacology and Therapeutics 16: 1052–1058 (1974).

    PubMed  CAS  Google Scholar 

  • McMahon, R.E.; Marshall, F.J. and Culp, H.W.: The nature of the metabolites of acetohexamide in the rat and in the human. Journal of Pharmacology and Experimental Therapeutics 149: 272–279(1965).

    PubMed  CAS  Google Scholar 

  • Melander, A.; Sartor, G.; Wahlin, E.; Schersten, B. and Bitzen, P.-O.: Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. British Medical Journal 1: 142–144 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Midha, K.K.; McGilveray, I.J. and Charette, C.: GLC determination of plasma levels of intact chlorpropamide and tolbutamide. Journal of Pharmaceutical Sciences 65: 576–579 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Miller, A.K.; Adir, J. and Vestal, R.E.: Tolbutamide binding to plasma proteins of young and old subjects. Journal of Pharmaceutical Sciences 67: 1192–1193 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Monro, A.M. and Welling, P.G.: The bioavailability in man of marketed brands of chlorpropamide. European Journal of Clinical Pharmacology 7: 47–49 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Nation, R.L.; Peng, G.W. and Chiou, W.L.: Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma. Journal of Chromatography 146: 121–131 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Nelson, E.: Rate of metabolism of tolbutamide in test subjects with liver disease or with impaired renal function. American Journal of the Medical Sciences 248: 657–659 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Nelson, E. and O’Reilly, I.: Kinetics of carboxytolbutamide excretion following tolbutamide and carboxytolbutamide, administration. Journal of Pharmacology and Experimental Therapeutics 132: 103–109 (1961).

    CAS  Google Scholar 

  • Nelson, E.; O’Reilly, I. and Chulsky, T.: Determination of carboxytolbutamide in urine. Clinica Chimica Acta 5: 774–776 (1960).

    Article  CAS  Google Scholar 

  • Nelson, E.; Knoechel, E.L.; Hamlin, W.E. and Wagner, J.G.: Influence of absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans. Journal of Pharmaceutical Sciences 51: 509–514 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Nieuweboer, B.; Gabriel, D. and Lübke, K.: Eine Methode zur radioimmunologischen Bestimmung von Glisoxepid. Arzneimittel-Forschung 26: 1633–1636 (1976).

    PubMed  CAS  Google Scholar 

  • Nilson, B. and Agren, A.: Complex formation between macromolecules and drugs. X. Binding of tolbutamide, chlorpropamide and carbutamide to human serum albumin, and the competition between tolbutamide or chlorpropamide and carbutamide or 4,sulfanilamido-2,6-dimethyl-pyridine for binding sites on human serum albumin. Acta Pharmaceutica Suecica 11: 391–400 (1974).

    Google Scholar 

  • Petitpierre, B.; Perrin, L.; Rudhardt, M.; Herrera, A. and Fabre, J.: Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy. International Journal of Clinical Pharmacology, Therapy and Toxicology 6(2): 120–124 (1972).

    PubMed  CAS  Google Scholar 

  • Prescott, L.F. and Redman, D.R.: Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma. Journal of Pharmacy and Pharmacology 24: 713–716 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Pyke, D.A.: Diabetes: The genetic connections. Diabetologia 17: 333–345 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Raaflaub, J.; Baethke, R.; Sorge, F. and Meier, J.M.: Pharmacokinetics of glibornuride and its metabolites in patients with renal disease. 7th International Congress of Pharmacology, pp. 16–21, July, Paris (1978).

  • Redman, D.R. and Prescott, L.F.: Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics. Diabetes 22: 210–211 (1973).

    PubMed  CAS  Google Scholar 

  • Remmer, H.; Siegert, M. and Merker, H.J.: Vermehrung arzneimitteloxydierender Enzyme durch Tolbutamid. Naunyn-Schmiedebergs Archiv Experimentelle Pathologie und Pharmakologie 249: 71–84 (1964).

    CAS  Google Scholar 

  • Rentsch, G.; Schmidt, H.A.E. and Rieder, J.: Zur Pharmakokinetik von Glibornurid. Arzneimittel-Forschung 22: 2209–2212 (1972).

    PubMed  CAS  Google Scholar 

  • Rufer, C.; Biere, H.; Ahrens, H.; Loge, O. and Schröder, E.: Blood glucose lowering sulfonamides with asymmetric carbon atoms. Journal of Medicinal Chemistry 17: 708–721 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Rupp, W.; Christ, O. and Heptner, W.: Resorption, Ausscheidung und Metabolismus nach intravenöser und oraler Gabe von HB 419-14C an Menschen. Arzneimittel-Forschung 19: 1428–1434 (1969).

    PubMed  CAS  Google Scholar 

  • Rupp, W.; Christ, O. and Fülberth, W.: Untersuchungen zur Bioavailability von Glibenclamid. Arzneimittel-Forschung 22: 471–473 (1972).

    PubMed  CAS  Google Scholar 

  • Sabih, K. and Sabih, K.: Gas chromatographic method for determination of tolbutamide and chlorpropamide. Journal of Pharmaceutical Sciences 59: 782–784 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Sartor, G.; Scherstén, B. and Melander, A.: Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. Acta Medica Scandinavica 203: 211–214 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Sartor, G.; Melander, A.; Schersten, B. and Wåhlin-Boll, E.: Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 18: 17–22 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Schlicht, H.J.; Gelbke, H.P. and Schmidt, G.: Gas chromatographic procedure for the simultaneous determination of five common antidiabetic drugs in blood. Journal of Chromatography 155: 178–181 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, F.H.: Pharmakokinetische und pharmakodynamische Wechselwirkungen antidiabetisch Wirkender Sulfonylharnstoffe; in Hoechst and Schattauer (Eds) Pharmacological and Clinical Significance of Pharmacokinetics, pp. 127–144 (Schattauer Verlag, Stuttgart 1970).

    Google Scholar 

  • Schmidt, F.H.; Hrstka, V.E.; Heesen, D.; Schulz, O. and Schulz, E.: Plasmaspiegel und Ausscheidung von Glibenclamid bei niereninsuffizienten und leberkranken Patienten im akuten Versuch. Abstract No. 89 (Ninth Kongress der Deutschen Diabetes-Gesellschaft, 1974).

  • Schmidt, H.A.E. and Petrides, Pl.: Glukose-und HB 419*-Konzentration im Blut sowie HB 419*- Ausscheidung im Urin nach einmaliger oraler Applikation von HB 419-14C. Arzneimittel-Forschung 19: 1422–1428 (1969).

    PubMed  CAS  Google Scholar 

  • Schmidt, H.A.E.; Schoog, M.: Schweer, K.H. and Winkler, E.: Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic. Diabetologia 9 (Suppl.): 320–330 (1973).

    Article  CAS  Google Scholar 

  • Schulz, E.: Schwere hypoglykämische Reaktionen nach den Sulfonylharnstoffen Tolbutamid, Carbutamid und Chlorpropamid. Archiv für Klinische Medizin 214: 135–162 (1968).

    PubMed  CAS  Google Scholar 

  • Schultz, E. and Schmidt, F.H.: Abbaukemmung von Tolbutamid durch Sulfaphenazol beim Menschen. Pharmacologia Clinica 2: 150–154 (1970).

    Article  Google Scholar 

  • Schulz, E.; Koch, K. and Schmidt, F.H.: Ursachen der Potenzierung der hypoglykämischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente. II. Pharmakokinetic und Metabolismus von Glibenclamid (HB 419) in Gegenwart von Phenylbutazon. European Journal of Clinical Pharmacology 4: 32–37 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Scott, J. and Poffenbarger, PL.: Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 28: 41–51 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Sehlin, J.: Evidence for specific binding of tolbutamide to the plasma membrane of the pancreatic B-cells. Acta Diabetologica Latina 10: 1052–1060 (1973).

    Article  CAS  Google Scholar 

  • Sheldon, J.; Anderson, J. and Stoner, L.: Serum concentration and urinary excretion of oral sulfonylurea compounds. Diabetes 14: 362–367 (1965).

    PubMed  CAS  Google Scholar 

  • Shen, S.W. and Bressler, R.: Clinical pharmacology of oral antidiabetic agents. Part I. New England Journal of Medicine 296: 493–497 (1977a).

    Article  PubMed  CAS  Google Scholar 

  • Shen, S.W. and Bressler, R.: Clinical pharmacology of oral antidiabetic agents. Part II. New England Journal of Medicine 296: 787–793 (1977b).

    Article  PubMed  CAS  Google Scholar 

  • Shibasaki, J.; Konishi, R.; Ueki, T. and Morishita, T.: Drug absorption, metabolism, and excretion. VIII. Determination of tolbutamide and its metabolites in blood and urine. Chemical and Pharmaceutical Bulletin 21: 1747–1753 (1973a).

    Article  CAS  Google Scholar 

  • Shibasaki, J.; Konishi, R.; Morishita, T. and Ueki, T.: Drug absorption, metabolism, and excretion. IX. Some new aspects of pharmacokinetics on tolbutamide in rabbits. Chemical and Pharmaceutical Bulletin 21: 1754–1763 (1973b).

    Article  CAS  Google Scholar 

  • Simmons, D.L.; Ranz, R.J. and Picotte, P.: Determination of serum tolbutamide by gas chromatography. Journal of Chromatography 71: 421–426 (1972).

    PubMed  CAS  Google Scholar 

  • Smith, D.L.; Vecchio, T.J. and Forist, A.A.: Metabolism of antidiabetic sulfonylureas in man. I. Biological half-lives of the p-acetylbenzenesulfonylureas, U-18536 and acetohexamide and their metabolites. Metabolism 14: 229–240 (1965).

    CAS  Google Scholar 

  • Sotaniemi, E.; Arvela, P.; Huhti, E. and Koiristo, O.: Half-life of tolbutamide in patients with chronic respiratory failure. European Journal of Clinical Pharmacology 4: 29–31 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Speck, U.; Mützel, W.; Kolb, K.H.; Acksteiner, B. and Schulze, P.E.: Pharmakokinetik und Metabolitenspektrum von Glisoxepid beim Menschen. Arzneimittel-Forschung 24: 404–409 (1974).

    PubMed  CAS  Google Scholar 

  • Spingler, H.: Uber eine Möglichkeit zur colorimetrischen Bestimmung von N-(methyl-benzolsulfonyl)- N′-butyl-harnstoff in Serum. Klinische Wochenschrift 35: 533–535 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Spingier, H.: Über eine Möglichkeit zur colorimetrischen Bestimmung von N-fmethyl-benzolsulfonyl)- N′-butyl-harnstoff in Forschung 12: 760–762(1956).

    Google Scholar 

  • Stowers, J.M.; Constable, L.W. and Hunter, R.B.: A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Annals of the New York Academy of Sciences 74: 689–695 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Stowers, J.M.; Mahler, R.F. and Hunter, R.B.: Pharmacology and mode of action of the sulphonylureas in man. Lancet 1: 278–283 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Tamassia, V.: The pharmacokinetics and bioavailability of glipizide. Current Medical Research and Opinion 3 (Suppl.): 20–30 (1975).

    Article  Google Scholar 

  • Taylor, J.A.: Pharmacokinetics and biotransformation of chlorpropamide in man. Clinical Pharmacology and Therapeutics 13: 710–718 (1972).

    PubMed  CAS  Google Scholar 

  • Taylor, T.; Assinder, D.F.; Chasseaud, L.F.; Bradford, P.M. and Burton, J.S.: Plasma concentrations, bioavailability and dissolution of chlorpropamide. European Journal of Clinical Pharmacology 11: 207–212 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Thomas, R.C. and Ikeda, G.J.: The metabolic fate of tolbutamide in man and in the rat. Journal of Medicinal Chemistry 9: 507–510 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Thomas, R.C. and Judy, R.W.: Metabolic fate of chlorpropamide in man and in the rat. Journal of Medicinal Chemistry 15: 964–968 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Toolan, T.J. and Wagner R.L., Jr: The physical properties of chlorpropamide and its determination in human serum. Annals of the New York Academy of Sciences 74: 449–458 (1958).

    Article  Google Scholar 

  • Uedą, H.; Sakurai, T.; Otal, M.; Nakajima, A.; Kami, K. and Maezawa, H.: Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis and renal disease. Diabetes 12: 414–419 (1963).

    PubMed  Google Scholar 

  • Vajda, F.J.E.; Williams, F. and Davies, D.S.: Measurement of plasma concentrations of tolbutamide by simplified gas-liquid chromatography. Medical Journal of Australia 1: 64–65 (1974).

    Google Scholar 

  • West, K.M. and Johnson, P.C.: The comparative pharmacology of tolbutamide, carbutamide, chlorpropamide and metahexamide in man. Metabolism 8: 596–605 (1959).

    PubMed  CAS  Google Scholar 

  • West, K.M. and Johnson, P.C.: Metabolism and relative hypoglycemic potencies of four sulfonylureas in man. Diabetes 9: 454–458 (1960).

    PubMed  CAS  Google Scholar 

  • Wickramasinghe, J.A.F. and Shaw, S.R.: GC determination of tolazamide in plasma. Journal of Pharmaceutical Sciences 60: 1669–1672 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Williams, R.L.; Blaschke, T.F.; Meffin, P.J.; Melmon, K.L. and Rowland, M.: Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide. Clinical Pharmacology and Therapeutics 21: 301–309 (1977).

    PubMed  CAS  Google Scholar 

  • Wishinsky, H.; Glaser, E.J. and Perkal, S.: Protein interactions of sulfonylurea compounds. Diabetes 11: 18–25 (1962).

    PubMed  Google Scholar 

  • Zini, R.; d’Athis, P.; Hoareau, A. and Tillement, J.P.: Binding of four sulphonamides to human albumin. European Journal of Clinical Pharmacology 10: 139–145 (1976).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Policlinique Universitaire de Médecine, Department of Medicine, University of Geneva, CH-1211, Geneva 4, Switzerland

    L. Balant

Authors
  1. L. Balant
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balant, L. Clinical Pharmacokinetics of Sulphonylurea Hypoglycaemic Drugs. Clin Pharmacokinet 6, 215–241 (1981). https://doi.org/10.2165/00003088-198106030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198106030-00003

Keywords

Search

Navigation